Investigation into Pfizer's Bio-NTech 162B2 Vaccine Trials

This chapter discusses the ongoing investigation into the clinical trials of Pfizer's bio-NTech 162B2 vaccine, including the challenges faced in obtaining the documents and their eventual release. It also mentions the involvement of various organizations and discusses upcoming topics and events.